Global Lupus Nephritis Industry Growth Analysis and Forecasts to 2030 Lupus Nephritis Market Global Analysis 2017 | Page 2

Lupus Nephritis Industry Global Market Analysis, Growth, Share, Industry
Trends and Forecasts to 2030
“Global Lupus Nephritis Market: Industry Analysis & Outlook (2021-2030)” analyses the development of
this market, with focus on the U.S, Europe and Japan markets. The major trends, growth drivers as well as
issues being faced by the market are discussed in detail in this report. The five major players: Aurinia
Pharmaceuticals Inc., Roche Holding AG, Bristol-Myers Squibb, GlaxoSmithKline Plc. and AstraZeneca are
being profiled along with their key financials and strategies for growth. The report contains a
comprehensive analysis of the global Lupus Nephritis market along with the study of the regional markets.
Company Coverage of Global Lupus Nephritis Market: Aurinia Pharmaceuticals Inc., Roche Holding AG,
Bristol-Myers Squibb, GlaxoSmithKline Plc.and AstraZeneca.
Lupus Nephritis market is set to experience favourable growth driven by factors such as increasing African-
American population, rising health care expenditure and accelerating economic growth. The major trends
observed in the market are new drugs under pipeline for Lupus Nephritis, increasing research grants with
rising public awareness about the disease. However, the growth of this budding market will be hindered by
stringent regulations, associated risk and high cost.
Complete report available at http://www.marketreportsonline.com/591762.html